Assessment of survival benefit with immunotherapy in combination with adjuvant chemoradiation in pathologic stage II-IIIB non-small cell lung cancer.

Authors: Natasha Venugopal, Jorge Raul Vazquez Urrutia, Junjia Zhu, Asato Hashinokuchi, Shinkichi Takamori, Takefumi Komiya

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.8018

Source: Full article

---

Abstract

8018